Heberlig Chris
Insider CIK 1532217 · ONVO President and CFO · KNSA Exec VP & CFO · GEVA Vice President, Finance
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ONVO ORGANOVO HOLDINGS, INC. | A Award deriv | 2020-09-15 | 2020-09-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2019-09-17 | 2019-09-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2019-03-04 | 2019-03-06 | 46,000 | — | $0 | 46,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2018-09-20 | 2018-09-24 | 45,000 | — | $0 | 45,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion deriv | 2018-05-29 | 2018-05-29 | 74,935 | — | $0 | 440,920 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion deriv | 2018-05-29 | 2018-05-29 | 6,392 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion deriv | 2018-05-29 | 2018-05-29 | 74,935 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion | 2018-05-29 | 2018-05-29 | 6,392 | — | $0 | 42,991 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | P Buy deriv | 2018-02-09 | 2018-05-29 | 6,392 | $15.64 | $100.0K | 6,392 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 5,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 7,500 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 12,500 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 12,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 838 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 82 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2015-06-22 | 2015-06-23 | 56 | $78.87 | $4.4K | 24,446 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer | 2015-06-22 | 2015-06-23 | 446 | — | $0 | 24,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer | 2015-06-22 | 2015-06-23 | 24,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2015-06-05 | 2015-06-09 | 24,000 | — | $0 | 24,390 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2015-03-11 | 2015-03-13 | 7,500 | — | $0 | 7,500 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-03-11 | 2015-03-13 | 600 | $101.38 | $60.8K | 6,390 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-03-11 | 2015-03-13 | 1,510 | $104.57 | $157.9K | 690 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-03-11 | 2015-03-13 | 3,290 | $103.55 | $340.7K | 2,200 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-03-11 | 2015-03-13 | 900 | $102.46 | $92.2K | 5,490 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-03-11 | 2015-03-13 | 300 | $105.74 | $31.7K | 390 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-03-11 | 2015-03-13 | 900 | $100.44 | $90.4K | 6,990 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2015-03-11 | 2015-03-13 | 7,500 | $40.74 | $305.6K | 7,890 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2015-03-11 | 2015-03-13 | 86 | $76.88 | $6.6K | 390 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-12-29 | 2014-12-30 | 5,000 | — | $0 | 5,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-12-29 | 2014-12-30 | 1,100 | — | $0 | 838 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-12-29 | 2014-12-30 | 1,156 | $92.10 | $106.5K | 604 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-12-29 | 2014-12-30 | 300 | $93.04 | $27.9K | 304 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-12-29 | 2014-12-30 | 2,844 | $91.34 | $259.8K | 1,760 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-12-29 | 2014-12-30 | 1,800 | $89.90 | $161.8K | 4,604 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-12-29 | 2014-12-30 | 5,000 | $23.00 | $115.0K | 6,404 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-12-29 | 2014-12-30 | 1,100 | $1.70 | $1.9K | 1,404 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2014-06-30 | 2014-07-02 | 112 | $54.89 | $6.1K | 304 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2014-06-04 | 2014-06-05 | 12,000 | — | $0 | 12,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-03-12 | 2014-03-14 | 820 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-03-12 | 2014-03-14 | 5,000 | — | $0 | 10,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-03-12 | 2014-03-14 | 1,850 | — | $0 | 1,938 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-03-12 | 2014-03-14 | 3,037 | $99.08 | $300.9K | 192 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-03-12 | 2014-03-14 | 820 | $0.95 | $779 | 2,862 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-03-12 | 2014-03-14 | 5,000 | $23.00 | $115.0K | 7,862 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-03-12 | 2014-03-14 | 700 | $96.75 | $67.7K | 7,162 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-03-12 | 2014-03-14 | 3,933 | $98.49 | $387.4K | 3,229 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-03-12 | 2014-03-14 | 1,850 | $1.70 | $3.1K | 2,042 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2013-12-31 | 2014-01-02 | 192 | $36.30 | $7.0K | 192 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-07-16 | 2013-07-17 | 2,029 | $48.26 | $97.9K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-07-15 | 2013-07-17 | 247 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-07-15 | 2013-07-17 | 400 | — | $0 | 3,788 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-07-15 | 2013-07-17 | 1,877 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-07-15 | 2013-07-17 | 400 | $1.70 | $680 | 400 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-07-15 | 2013-07-17 | 495 | $49.15 | $24.3K | 2,029 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-07-15 | 2013-07-17 | 1,877 | $0.95 | $1.8K | 2,524 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-07-15 | 2013-07-17 | 247 | $0.95 | $235 | 647 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2013-06-06 | 2013-06-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2012-12-19 | 2012-12-21 | 4,000 | — | $0 | 1,877 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2012-12-19 | 2012-12-21 | 4,000 | $0.95 | $3.8K | 4,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-12-19 | 2012-12-21 | 1,605 | $46.07 | $73.9K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-12-19 | 2012-12-21 | 2,395 | $45.83 | $109.8K | 1,605 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2012-10-17 | 2012-10-19 | 2,000 | — | $0 | 820 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2012-10-17 | 2012-10-19 | 2,000 | — | $0 | 4,188 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-10-17 | 2012-10-19 | 2,000 | $49.64 | $99.3K | 2,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-10-17 | 2012-10-19 | 2,000 | $49.67 | $99.3K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2012-10-17 | 2012-10-19 | 2,000 | $1.70 | $3.4K | 2,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2012-10-17 | 2012-10-19 | 2,000 | $0.95 | $1.9K | 4,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2012-09-04 | 2012-09-06 | 1,000 | — | $0 | 5,877 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-09-04 | 2012-09-06 | 700 | $48.92 | $34.2K | 300 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2012-09-04 | 2012-09-06 | 1,000 | $0.95 | $950 | 1,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-09-04 | 2012-09-06 | 300 | $49.52 | $14.9K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2012-06-27 | 2012-06-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2012-06-01 | 2012-06-05 | 1,000 | — | $0 | 6,877 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-06-01 | 2012-06-05 | 200 | $36.44 | $7.3K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-06-01 | 2012-06-05 | 800 | $35.56 | $28.4K | 200 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2012-06-01 | 2012-06-05 | 1,000 | $0.95 | $950 | 1,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2012-02-27 | 2012-02-29 | 4,500 | — | $0 | 7,877 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2012-02-27 | 2012-02-29 | 4,500 | $36.88 | $166.0K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2012-02-27 | 2012-02-29 | 4,500 | $0.95 | $4.3K | 4,500 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2011-12-20 | 2012-01-11 | 15,000 | — | $0 | 15,000 | SEC↗ |